Abstract Aging is an important factor in memory decline in aged animals and humans and in Alzheimer's disease and is associated with the impairment of hippocampal long-term potentiation (LTP) and downregulation of NR1/NR2B expression. Gaseous formaldehyde exposure is known to induce animal memory loss and human cognitive decline; however, it is unclear whether the concentrations of endogenous formaldehyde are elevated in the hippocampus and how excess formaldehyde affects LTP and memory formation during the aging process. In the present study, we report that hippocampal formaldehyde accumulated in memorydeteriorating diseases such as age-related dementia. Spatial memory performance was gradually impaired in normal Sprague-Dawley rats by persistent intraperitoneal injection with formaldehyde. Furthermore, excess formaldehyde treatment suppressed the hippocampal LTP formation by blocking N-methyl-D-aspartate (NMDA) receptor. Chronic excess formaldehyde treatment over a period of 30 days markedly decreased the viability of the hippocampus and down-regulated the expression of the NR1 and NR2B subunits of the NMDA receptor. Our results indicate that excess endogenous formaldehyde is a critical factor in memory loss in age-related memory-deteriorating diseases.
) and a pathogenic factor for Alzheimer's disease (AD) (Drachman 2006; Cummings 2008) . Abundant evidence shows that memory decline occurs and hippocampal long-term potentiation (LTP) is impaired in aged animals (Almaguer et al. 2002; Chapman et al. 1999; Kamal et al. 2005 ) and memory-deteriorating animal models such as amyloid precursor protein (APP) transgenic mice (Gureviciene et al. 2004) , APP/PS1 mice (Gengler et al. 2010) , and senescence-acceleratedprone 8 mice (SAMP8) (López-Ramos et al. 2012) . NR2B, one of the subunits of N-methyl-D-aspartate (NMDA) receptor, is critical in regulating the agedependent synaptic plasticity and memory formation (Tang et al. 1999 ). In addition, expression of NR1 and NR2B markedly decreases in the hippocampus of APP transgenic mice, aged rats (Mesches et al. 2004) , and AD patients (Amada et al. 2005; Hynd et al. 2004) . However, which endogenous factors associated with the decline in NR1/NR2B expression contribute to memory impairment has not been ascertained.
Formaldehyde is present in the cytoplasm and nucleus of all cells (Kalapos 1999; Kalász 2003; Trézl et al. 1997; Tyihák et al. 1998 ). Using fluorescence highperformance liquid chromatography (Fluo-HPLC), we have shown that the levels of brain formaldehyde are about 0.2-0.4 mM, similar to the levels previously reported using gas chromatography/mass spectrometry (Heck et al. 1982; Tong et al. 2011) . There is abundant evidence indicating that excess formaldehyde can impair memory. Exposure of rats to exogenous gaseous formaldehyde induces the accumulation of formaldehyde (Cui 1996) , decreases the number of hippocampal neurons (Gurel et al. 2005) , and leads to memory decline (Malek et al. 2003) . Epidemiological investigations indicate that exogenous formaldehyde exposure causes human cognitive decline and is associated with neurofilament protein changes and demyelization in hippocampal neurons (Kilburn 1994; Kilburn et al. 1987; Perna et al. 2001 ). In addition, we have previously reported that brain tissues from AD animal models have abnormally high levels of formaldehyde (about 0.5 mM) and that treatment of normal mice with 0.5 mM formaldehyde induces marked memory decline (Tong et al. 2011) . These diverse lines of evidence strongly suggest that excess endogenous formaldehyde is a pathogenic factor involved in memory decline.
To understand how excess formaldehyde induces memory decline, we first detected endogenous formaldehyde levels during the aging process and in age-related memory-deteriorating diseases. We then ascertained whether excess hippocampal formaldehyde affected LTP and spatial memory formation in Sprague-Dawley (SD) rats. In addition, we examined whether excess formaldehyde regulated NR1 and NR2B expression. Our results show that excess hippocampal formaldehyde suppresses LTP and spatial memory formation not only by non-specifically blocking NMDA receptor, but also by decreasing NMDA receptor expression.
Materials and methods

Reagents
All reagents were from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise indicated.
Animal models and brain tissue collection
All animal experiments were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Biological Research Ethics Committee, Institute of Biophysics, Chinese Academy of Sciences (SYXK2010-127). APP transgenic mice model APP transgenic mice were obtained from the Chinese Academy of Medical Sciences (Beijing).
Diabetic rat model Since Reisi and colleagues have demonstrated that streptozotocin (STZ)-induced diabetic SD rats show memory decline after 3 months (Reisi et al. 2009 ), this model was employed in this work. To induce diabetes in male SD rats (2503 00 g), STZ was freshly dissolved in 0.05 M citrate buffer, pH 4.5, and a single intraperitoneal (i.p.) injection (150 mg/kg) was given to each animal. Animals whose blood glucose exceeded 200 mg/dl 24 h after treatment were considered diabetic (Abu-Abeeleh et al. 2010) .
Human brain samples Autopsy hippocampal and cortical tissues from healthy controls and Alzheimer's disease patients were obtained from the Netherlands Brain Bank.
Acute formaldehyde injection for seven consecutive days The normal male SD rats (250-300 g) were intraperitoneally (i.p.) administered with formaldehyde once a day at 0.5 mM formaldehyde (60 mg/ kg) prior to Morris water maze training and were then used for memory behavior tests or formaldehyde level detection.
Chronic formaldehyde injection for 30 days The normal male SD rats were intraperitoneally injected with 0.5 mM formaldehyde (i.p. 60 mg/kg) over a period of 30 consecutive days (Gurel et al. 2005; Tong et al. 2011 ). Hippocampal formaldehyde concentrations were then detected by Fluo-HPLC after completion of Morris water maze testing.
Hippocampal neuron and astrocyte culture in vitro
We prepared primary hippocampal neuron cultures from 18-day-old embryos, as described previously (Nie et al. 2007a) . Medium from the mature hippocampal neuron culture (cultured for 14-16 days) was collected in order to detect formaldehyde concentration. Astrocytes were cultured as reported previously (Song et al. 2010 ).
Morris water maze behavioral test
Four groups of normal male SD rats were intraperitoneally injected with normal saline, 0.5 mM formaldehyde (i.p. 60 mg/kg), resveratrol (1 mM), or formaldehyde with resveratrol over a period of 30 consecutive days (Gurel et al. 2005; Tong et al. 2011) . Spatial memory behaviors of rats were assessed by the Morris water maze test, as described previously (Morris 1984) .
Quantification of extracellular formaldehyde by Fluo-HPLC Drug-treated medium from cultured hippocampal neurons was collected and immediately placed on ice before storing at −70°C. After centrifugation (3,000 rpm, 4°C, 10 min), supernatants from the above culture medium samples and brain homogenates (weight of brain tissue/ ultrapure water01:4) were analyzed by Fluo-HPLC as described (Luo et al. 2001 ).
Cytosolic free Ca 2+ concentration in NR1/NR2B-transfected CHO cells in vitro For transfection of pcDNA3.1-GFP-NR1a and pcDNA3.1-NR2B plasmids (gifts from Dr. Jianhong Luo, Zhejiang University, China), Chinese hamster ovary (CHO) cells were harvested after a brief trypsin digestion and seeded onto chambered cover glasses (LabTek, Nunc, USA) precoated with 20 μg/ml poly-L-lysine. Actively growing cells were transfected with these two plasmids using Lipofectamine plus (Life Technologies, Rockville, MD, USA). The cells transfected with pcDNA3.1 plasmid alone were set as control. After 162 4 h of culture, cells were loaded with 50 μM Fluo-3/AM (Molecular Probes) and incubated for 30 min at 37°C. Fluo-3/AM was excited at 488 nm, and its emitted fluorescence was collected at 515 nm. These cells were then treated with 0.2 mM NMDA plus 0.01 mM glycine or NMDA with formaldehyde at different concentrations (0, 0.3, and 0.5 mM). Changes in cytosolic free Ca 2+ concentration ([Ca 2+ ] i ) in these cells were measured with a confocal laser scanning microscope (Leica Company Ltd, Germany) as described previously (Tong et al. 2010 ).
Recording hippocampal LTP in vivo
Electrophysiological recordings were performed as described in previous reports (Cheng et al. 2009; ). The normal male SD rats (250-300 g) were placed in a stereotaxic frame and the recording electrode was positioned in the stratum radiatum of area CA1 (3.4 mm posterior to the bregma and 2.5 mm lateral to the midline); a bipolar concentric stimulating electrode was placed in the Schaffer collateral-commissural pathway (4.2 mm posterior to the bregma and 3.8 mm lateral to the midline) distal to the recording electrode.
Baseline stimulation (BS) for field excitatory postsynaptic potentials (fEPSPs) Baseline fEPSPs were elicited by BS at intervals of 30 s at an intensity that elicited 50% of the maximal response. Baseline fEPSPs were monitored for at least 30 min prior to the induction of LTP to ensure a steady-state response.
Intracerebroventricular formaldehyde injections Three groups of SD rats were intracerebroventricularly (i.c. v.) injected with formaldehyde (normal saline, 0.3 and 0.5 mM, 5 μl, i.c.v. in 5 min) before high frequency electrical stimulation (HFS) for 30 min and were then subjected to electrophysiological experiments or hippocampal formaldehyde detection.
HFS for LTP LTP was induced using an HFS protocol consisting of 20 pulses at 100 Hz. A >50% increase in fEPSP amplitude from the baseline was considered as a significant LTP. Drug or normal saline intracerebroventricular injections (i.c.v. 5 μl, in 5 min) were carried out 30 min before different stimulations. After electrophysiological recordings, hippocampi from these different groups of rats were collected to detect formaldehyde concentration.
Hippocampal viability assays
Four groups of normal SD rats (250-300 g) were injected with normal saline, 0.5 mM formaldehyde (i.p. 60 mg/ kg), resveratrol (1 mM), or formaldehyde with resveratrol, respectively, over a period of 30 consecutive days, and then hippocampal slices (300 μm) of these rats were dyed with an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution. Photomicrographs were typically obtained after 1 h of incubation with MTT as described in previous reports (Connelly et al. 2000) .
Hippocampal neuron and astrocyte viability assays
Cell viability was assessed by the MTT assay as previously described (Tong et al. 2010) . Hippocampal neurons and astrocytes were treated with various concentrations of formaldehyde for 3 h. An MTT solution was freshly prepared in complete medium at a concentration of 1 mg/ ml. Absorbance at 540 nm was measured on a Multiscan MK3 spectrophotometer (Thermo, USA).
Western blotting
Control, formaldehyde-treated hippocampal neurons, and hippocampus samples were lysed with a protein extraction reagent (M-PER; Thermo Scientific, Rockford, IL, USA). Protein concentrations were determined with BCA protein assay reagent using a standard protocol. Equivalent amounts of proteins were separated on SDS-PAGE gels, transferred to nitrocellulose membranes (Millipore, Bedford, MD, USA), and incubated with antibodies to NR1 (1:2,000, Cell Signaling Technology, Inc. USA), NR2B (1:1,500), and AMPA (GluR 2/3/4) (1:2,000). β-actin was used as a gel-loading control. Protein bands were visualized after exposing the membranes to Kodak X-ray film and were quantified by densitometry. Results are presented as total integrated densitometric values. Statistics fEPSPs were expressed as a percentage of the mean baseline amplitude (set arbitrarily as 100%). Statistical comparisons of the LTP from control and drug-treated groups were carried out at 5, 30, and 60 min after HFS treatment. We determined the statistical significance of data by conducting an analysis of variance followed by the unpaired Student'st test. The level for statistical significance was set at P<0.05. Data are reported as means±standard error.
Results
Endogenous formaldehyde concentrations increase in age-related memory-deteriorating diseases
To determine whether endogenous formaldehyde is related to aging, we investigated the blood and urine formaldehyde levels of people of different ages (Fig. 1a, b ). There was a slight increase in blood formaldehyde concentration with aging (from 0 to 70 years old); however, there was a marked elevation in the elderly group over 79 years old. Urine formaldehyde levels of elderly people (65-75 years old) were also significantly higher than those of young volunteers (22-28 years old) (P<0.01). Since it is extremely difficult to obtain human brain samples from enough people of different ages, we detected the brain formaldehyde concentrations of SD rats and C57BL/6 mice at different ages in our experiments. As shown in Fig. 1c, d , hippocampal formaldehyde levels in rats aged 6-24 months were significantly higher than those of 1-month-old rats (P<0.01), and brain formaldehyde levels of 8-month-old mice were higher than those of 3-month-old mice (P<0.01). This indicates that endogenous formaldehyde levels increase with aging.
Alzheimer's disease patients often suffer from progressively worsening memory problems. As shown in Fig. 1e , the hippocampal formaldehyde level of Alzheimer's patients was significantly higher than that of age-matched controls or young people (P<0.01). The cortical formaldehyde level of Alzheimer's disease patients was slightly higher than that of controls, but this difference did not reach significance (Fig. 1f) . Furthermore, the brain formaldehyde level of APP +/+ transgenic mice was significantly higher than that of APP −/− mice 6 months old (Fig. 1g) . Since Reisi and colleagues have demonstrated that STZ-induced diabetic SD rats show memory decline (Reisi et al. 2009 ), we measured formaldehyde levels in the hippocampi of STZ-induced diabetic SD rats after 3 months. Similarly, there was a marked increase in hippocampal formaldehyde level of diabetic rats compared with controls (P<0.01) (Fig. 1h) . These data strongly suggest that excess formaldehyde (over 0.5 mM) in the brain is closely related with memory loss in these memory-deteriorating diseases.
Excess formaldehyde suppresses hippocampal LTP in vivo
Accumulation of endogenous formaldehyde induces LTP suppression
We next used the inhibitors of the formaldehydedegrading enzymes alcohol dehydrogenase 3 (ADH3) and aldehyde dehydrogenase 2 (ALDH2) (Teng et al. 2001) to examine whether excess formaldehyde affects LTP formation. Hippocampal formaldehyde levels increased to over 0.5 mM 30 min after rats had been injected i.c.v. with succinic acid (an inhibitor of ADH3) ( Fig. 2a ) (Denk et al. 1976) , and a dose-dependent decrease of fEPSP amplitude was also observed (Fig. 2b, c) . Injection of daidzin (a selective inhibitor of ALDH2) (Kollau et al. 2005 ) gave a similar result ( Fig. 2d-f ). These data suggest that the LTP suppression by excess hippocampal formaldehyde is associated with the inhibition of ADH3 or ALDH2 in vivo.
Direct injection with exogenous formaldehyde suppresses LTP formation
To further confirm the effect of excess hippocampal formaldehyde on LTP formation, different concentrations of formaldehyde (normal saline, 0.3 and 0.5 mM) were injected (i.c.v.) into SD rats. The hippocampal formaldehyde level rose to about 0.52 mM 30 min after injection (Fig. 2g) , and the fEPSP amplitude was markedly reduced at this level of formaldehyde in vivo (P<0.01) (Fig. 2h, i) . Exogenous formaldehyde injections (0.5 mM) did not affect the baseline of the fEPSP recorded for 1 h post-injection (Fig. 2h) . These data support our hypothesis that excess hippocampal formaldehyde suppresses the LTP formation in vivo. To explore whether this is the case, NR1 and NR2B expression plasmids (pcDNA3-GFP-NR1 and pcDNA3-NR2B) were co-transfected into CHO cells. Expression of these transfected plasmids was confirmed by agarose gel electrophoresis and western blotting (Fig. 3a, b) . The effects of different concentrations of ] i were then measured by confocal laser scanning microscopy. We found that excess formaldehyde nonspecifically inhibited NMDA-induced Ca 2+ influx (Fig. 3c, d ). This result is similar to the report suggesting that excess ethanol inhibits NMDA-induced Ca 2+ influx in NR1/NR2B-transfected HEK 293 cells (Blevins et al. 1997) . Our results suggest that excess formaldehyde (0.5 mM) can non-specifically inhibit functions of the NR1/NR2B subunits of the NMDA receptor.
Acute and chronic excess formaldehyde treatments impair spatial memory in rats Acute injection with formaldehyde slows spatial memory formation
Since our results indicated that excess hippocampal formaldehyde induces LTP suppression (Fig. 2) , excess formaldehyde might also affect the spatial memory of rats. To test this hypothesis, we treated SD rats with formaldehyde 
v.) after 30 min (d). Effects of daidzin on LTP (e). Statistical analyses of EPSP amplitude (f)
. Formaldehyde levels in hippocampi after these rats were intracerebroventricularly treated with excess formaldehyde for 30 min (g). Excess formaldehyde induces LTP suppression (h). Statistical analysis of EPSP amplitude (i). *P<0.5; **P<0.01 (0.5 mM, i.p. 60 mg/kg) over a period of 7 days. Spatial learning ability of the formaldehyde-treated rats was insignificantly gradually decreased (P>0.05), but memory retrieval ability was markedly reduced (P < 0.05) (Fig. 4a, b) as hippocampal formaldehyde levels increased (Fig. 4c) . This demonstrates that excess hippocampal formaldehyde inhibits spatial memory formation in rats.
Chronic injection with formaldehyde induces spatial memory deficits
The above experiments show that acute excess formaldehyde (0.5 mM) treatment can reduce fEPSP amplitude and inhibit spatial memory formation (Figs. 2 and 4b, c) . However, age-related dementia involves chronic gradual and irreversible memory decline and neurodegeneration. We therefore examined whether chronic excess formaldehyde treatment over a period of 30 days induces memory decline in rats. We injected normal adult SD rats intraperitoneally with 0.5 mM formaldehyde (60 mg/kg, i.p.) for 30 consecutive days. Results showed that excess formaldehyde suppressed hippocampal LTP in vivo. The amplitude of fEPSP in these groups (140%, Fig. 4d ) was markedly lower than that (160%, Fig. 2h ) of SD rats injected (i.c.v.) with excess formaldehyde. Significantly, there was a decline in learning and memory retrieval ability in the formaldehyde-treated group. Resveratrol, an exogenous formaldehyde scavenger ), substantially rescued (P<0.01) rat hippocampal LTP suppression caused by excess formaldehyde (Fig. 4d, e) . That is to say, resveratrol markedly rescued (P<0.01) excess formaldehyde-induced cognitive decline and decreased levels of hippocampal formaldehyde (Fig. 4f-i) . This study demonstrates that chronic excess formaldehyde induces persistent memory loss.
Chronic excess formaldehyde induces hippocampal neurotoxicity in formaldehyde-treated rats Atrophy of the hippocampus is a typical pathological characteristic of Alzheimer's disease and occurs from the early to the final stages of the disease. The hippocampus is not only a critical organ for short-term memory formation, but also a transfer station for LTM (Nakazawa et al. 2004 ). We therefore examined whether chronic excess formaldehyde treatment over a period of 30 days induces hippocampus impairment. Viability of hippocampal slices (300 μm) from rats injected with excess formaldehyde for 30 days was markedly lower than that of controls (P<0.01). In addition, resveratrol, a formaldehyde scavenger, rescued formaldehyde-induced neurotoxicity of the hippocampus (Fig. 5a, b) .
To further confirm that the neurotoxicity was directly derived from excess formaldehyde (0.5 mM), hippocampal neurons and astrocytes were cultured in vitro. After treating with different concentrations of formaldehyde for 3 h, the viability of hippocampal neurons and astrocytes was decreased to a greater extent in the 0.5-and 1.2-mM formaldehyde treatment Fig. 4 Acute or chronic excess formaldehyde impairs spatial memory in rats. Escape latency in controls and rats injected with formaldehyde for 7 days (a). Time (seconds) spent in the target quadrant during probe trials (b). Formaldehyde levels in hippocampi from rats intraperitoneally treated with excess formaldehyde on day 7 (c). An exogenous supply of the formaldehyde scavenger resveratrol rescued LTP suppression by formaldehyde injection (i.p.) over 30 consecutive days (d). Statistical analysis of EPSP amplitude (e). Escape time (seconds) in these four groups (f). The swimming track and the time (seconds) spent in the target quadrant during probe trials (g, h). Formaldehyde levels in the hippocampus of rats intraperitoneally treated with different reagents on day 30 (i). *P<0.5; **P<0.01 groups compared with the respective controls (P< 0.01) (Fig. 5c, d ), indicating that excess formaldehyde directly leads to hippocampal impairment.
NR1/NR2B expression in hippocampal neurons relates with formaldehyde
Since the age-related decrease in the expression of NR2B is correlated with memory decline (Tang et al. 1999) , if excess formaldehyde is a critical risk factor for memory loss in aging and AD patients, excess formaldehyde is speculated to decrease NR2B expression in the chronic formaldehyde treatment groups. To test this hypothesis, we detected NR1 and NR2B expression in vitro and in vivo by western blotting. NR1 expression of primary cultured hippocampal neurons increased in the presence of formaldehyde at 0.08 mM and decreased at 0.5 mM (P<0.01) or higher concentration. NR2B expression markedly decreased at 1.2 mM formaldehyde (P<0.01) (Fig. 6a-d) . Furthermore, NR1 and NR2B expression increased in hippocampi of SD rats that had been treated with 0.5 mM formaldehyde for 7 days, but significantly decreased for 30 days (P<0.01). Formaldehyde had little effect on AMPA receptor expression ( Fig. 6e-h ) under the experimental conditions. This indicates that changes in NR1 and NR2B expression are related with the level and duration of excess formaldehyde accumulated in the hippocampus of rats.
Discussion
In the present study, we provide evidence that excess hippocampal formaldehyde is an endogenous pathogenic factor in memory decline in age-related memorydeteriorating diseases. It is widely accepted that aging leads to memory loss in aged animals and humans, especially in Alzheimer's disease (McGahon et al. 1999 ). Our study shows that endogenous formaldehyde is accumulated in aged animals and Alzheimer's disease patients (Fig. 1) . That formaldehyde is a small molecule (M.W. 0 30) and able to permeate the blood-brain barrier (Grönvall et al. 1998; Shcherbakova et al. 1986 ) may explain why chronic excess formaldehyde induces wide neurotoxicity in the brain (Fig. 5) . This neurotoxicity includes impairment of the hippocampus (Gurel et al. 2005) , neurofilament protein changes (He et al. 2010) , hyperphosphorylation of Tau protein , and demyelization of hippocampal neurons (Kilburn 1994; Kilburn et al. 1987; Perna et al. 2001 ). Physiological and/or pathological accumulation of formaldehyde is affected by a number of factors. (1) Aging: Recent research has shown that DNA demethylation leads to formaldehyde generation (Patra et al. 2008; Wu and Zhang 2010) . A genome-wide decline in DNA methylation (DNA demethylation) occurs in the brain during normal aging, and aging accelerates memory decline (Liu et al. 2009 ). In this study, formaldehyde levels were markedly higher in aged mice and rats (Fig. 1c, d ). These data hint that wide global DNA demethylation may be an endogenous factor for formaldehyde accumulation during the aging process or in Alzheimer's disease. (2) Environmental pollutants: For example, environmental mercury contamination, which is believed as a pathogenic factor for Alzheimer's disease (Ely 2001) , induces formaldehyde accumulation in vivo (Retfalvi et al. 1998) . (3) Diet: Formaldehyde participates in the "onecarbon cycle" (Kalász 2003) . Deficiencies of vitamin B 12 or folate in the diet lead to dysfunction of onecarbon metabolism in Alzheimer's patients (Coppedè 2010) . (4) Tumor: Cancer is known to be related to the occurrence of Alzheimer's disease (Burke et al. 1994) , and cancer cells and tumor tissues release higher levels of formaldehyde than normal cells and tissues (Tong et (Teng et al. 2001) , are related to memory. ADH3 is distributed in brains and contributes to defending the brain against neurodegenerative processes (Mori et al. 2000) . However, ADH3 is a glutathione-dependent enzyme; levels of glutathione in brains decline during aging (Zhu et al. 2006) . Therefore, decrease of ADH3 activity could lead to formaldehyde accumulation in brains with aging. ALDH2 polymorphism, which can result in the low activity of ALDH2 (Wang et al. 2008) , is related to susceptibility to late-onset Alzheimer's disease (Wang et al. 2002) . Knockout of ALDH2 induces age-dependent neurodegeneration with accompanying memory loss (Ohsawa et al. 2008) . (6) Genetic factor: Notably, amyloid 1-40 induces global DNA demethylation in vitro , and excess formaldehyde is observed in APP transgenic (hypomethylation of APP gene) mice when memory started to decline on month 6 (Tong et al. 2011) . This hints that DNA demethylation of APP induces formaldehyde accumulation. Taken together, aging, diet, environmental pollution, enzyme dysfunction, and related genetic factors, all can induce endogenous formaldehyde accumulation.
As mentioned above, the concentrations of blood and urine formaldehyde changed in the aging process. The endogenous formaldehyde concentrations were statistically increased (P<0.05) in people aged more than 70 years (Fig. 1a, b) , and it should be noted that samples from people with dementia were not ruled out. Furthermore, we found that the level of hippocampal formaldehyde of AD patients was significantly increased. However, the hippocampal formaldehyde of humans without dementia at the age of 65-78 did not increase significantly (P>0.05) compared to that of people at the age of 22-31 (Fig. 1e) . According to an epidemiological investigation, the frequency of dementia doubles every 5 years, increasing from affecting 1% of individuals 60-64 years of age to 8% of those 75-79 years of age and to 35-45% of those >85 years of age (Cummings 2008) . This suggests that endogenous formaldehyde increases with the aging process, similar to the frequency change in the onset of age-related dementia.
Furthermore, we have elucidated that molecular mechanisms of excess formaldehyde impair synaptic plasticity and spatial memory. NMDA receptor is a critical molecule for LTP and memory formation, and blocking the NMDA receptor induces memory loss (Tang et al. 1999 ). In our study, first, we demonstrated that excess formaldehyde suppresses hippocampal LTP and spatial memory formation in rats (Figs. 2 and 4) , consistent with other reports of hippocampal LTP suppression and memory decline in aged mice and rats (Almaguer et al. 2002; Chapman et al. 1999; Kamal et al. 2005) , STZ-induced diabetic SD rats (Reisi et al. 2010) , and Alzheimer's disease animal models such as APP transgenic mice (Gureviciene et al. 2004) , APP/ PS1 mice (Gengler et al. 2010) , and SAMP8 (López-Ramos et al. 2012) . Second, we showed that excess formaldehyde non-specifically blocks the NR1/NR2B subunits of the NMDA receptor in vitro (Fig. 3 ). An analogous study has shown that ethanol inhibits LTP formation by blocking the NMDA receptor, possibly because the cysteine residues of NR2B are sensitive to ethanol (Herin et al. 2001) , and leads to amnesia (Brioni et al. 1989; Dildy and Leslie 1989; Tokuda et al. 2007; Wirkner et al. 1999) . Some studies have shown that formaldehyde can spontaneously modify the cysteine residues of proteins (Metz et al. 2006; Toews et al. 2008) . We therefore hypothesized that formaldehyde may modify the cysteine residues of NR1 or NR2B, although the specific residues involved need further investigation. Taken together, excess formaldehyde affects LTP and memory formation by non-specifically blocking NMDA receptor.
Another critical question is whether chronic excess formaldehyde treatment induces the decreased expression of NR1 and NR2B. It is known that NR1 and NR2B are both necessary for long-term memory formation (Nakazawa et al. 2004) , since knockout of either NR1 or NR2B induces cognitive deficits in mice (Clayton et al. 2002; Rondi-Reig et al. 2006 ). In our study, NR2B expression initially increased then decreased in cultured hippocampal neurons after treatment with different concentrations of formaldehyde in vitro ( Fig. 6a-d) . Interestingly, the expression of NR1 and NR2B was increased in the hippocampus of the formaldehyde-treated groups after 7 days of formaldehyde treatment (Fig. 6e-h ), consistent with a previous study indicating that acute formaldehyde treatment increases NR1 and NR2B expression (Gaunitz et al. 2002) . We speculate that the increase in NR1/NR2B expression on day 7 compensates for the non-specific blocking of the NMDA receptor by excess formaldehyde. Some previous reports support this viewpoint. For example, chronic ethanol treatment, which induces amnesia (Brioni et al. 1989) , up-regulates the expression of the NMDA receptor in vitro and in vivo (Henniger et al. 2003; Kalluri et al. 1998 ). Memory behavior is impaired in the Rett syndrome mice model even though hippocampal NR2B expression is increased (Asaka et al. 2006) .
The expression of NR2B, a molecule that is critical for memory formation, declines with aging (Tang et al. 1999) . Down-regulation of NR1 and NR2B expression has been found in the brains of APP transgenic mice (Dewachter et al. 2009 ), aged rats (Mesches et al. 2004) , and AD patients (Amada et al. 2005; Hynd et al. 2004 ). As mentioned above, significant memory decline was associated with a decrease in NR1 and NR2B expression after 30 days of chronic excess formaldehyde treatment (Fig. 6e-h ). Endogenous formaldehyde gradually accumulates in the brains of mice, rats, and humans during the process of aging and in AD patients (Fig. 1) . Recent research has shown that long-term excess formaldehyde treatment induces up-regulation of DNA methyltransferases (DNMT1a) in 16HBE cells (Liu et al. 2011) . DNMT binds with the promoter of NR2B, and up-regulation of DNMT leads to the silencing of NR2B (Lee et al. 2008) . Our data along with these reports strongly suggest that chronic excess formaldehyde induces memory loss by decreasing NR1 and NR2B expression.
In conclusion, excess endogenous formaldehyde is a pathogenic factor in aged-dependent memory decline. Excess formaldehyde not only suppresses hippocampal LTP by blocking NMDA-receptor, but also persistently induces spatial memory deterioration by decreasing expression of the NMDA receptor. Furthermore, excess formaldehyde can induce amyloid or Tau protein aggregation, two of the markers of the late stages of Alzheimer's disease (Chen et al. 2006; Nie et al. 2007a, b) . The formaldehyde scavenger resveratrol can directly decrease hippocampal formaldehyde levels (Tong et al. 2011 ) and the numbers of senile plaques in APP transgenic mice (Karuppagounder et al. 2009 ), although the activation of other pathways by resveratrol has not been ruled out (Sun et al. 2010) . These data suggest that the scavenger of hippocampal formaldehyde is a potential and beneficial therapeutic target for age-related memory decline and neurodegeneration.
